NDC 49281-726
Flublok Trivalent Northern Hemisphere 45 ug per 0.5 mL injection
On the label: Sanofi Vaccines US Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Adimmune Corporation | Taichung City, Taiwan | Makes it | Not inspected on record |
| Protein Sciences Corporation | Pearl River, NY, United States | Makes the active ingredient and tests it | Not inspected on record |
| Unigen Inc. | Ibi-Gun, Japan | Makes the active ingredient | Not inspected on record |
| Advanced Therapies, LLC | Philadelphia, PA, United States | Tests it | No problems foundFeb 7, 2025 · 5 inspections |
Product details
- Generic drug
- Influenza A Virus A/Darwin/1415/2025 (h3n2) Recombinant Hemagglutinin Antigen and Influenza A Virus A/Missouri/11/2025 (h1n1) Recombinant Hemagglutinin Antigen and Influenza B Virus B/Pennsylvania/14/2025 Recombinant Hemagglutinin Antigen: every company that makes it
- Form
- injection, intramuscular
- Strength
- 45 ug per 0.5 mL
- Approval
- BLA BLA125285
- On the market since
- Jul 2, 2026
- Package NDCs
49281-726-1049281-726-88- Official label
- DailyMed (National Library of Medicine), updated Jul 1, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?